Venture Capital

The U.S. Highbush Blueberry Council is betting on startups to find new uses for blueberries in everything from skincare to pet food. Here's what's next.

With a new industry giant on its board and fresh funding, Phagenesis is set to scale its groundbreaking neuromodulation therapy for swallowing disorders.

Shanghai's Vivacta Bio raises over $50M from top VCs to revolutionize cancer treatment with its pioneering in vivo CAR-T therapy, GT801.

A novel, FDA-cleared wound therapy is rolling out to military and veteran hospitals, aiming to rewrite the rules of healing for the most complex injuries.

MindBio's new tech detects intoxication from your voice, promising safer workplaces but sparking major debate over surveillance, bias, and data privacy.

Scottish biotech EnteroBiotix secures major funding to advance its gut therapy for IBS-C, offering new hope for a disease-modifying treatment.

Metals Australia unveils a major graphite refinery in Baie-Comeau, promising a huge economic boost and a key role in the West's critical mineral strategy.

A record-breaking investment in AI for war ignites a fierce debate over autonomous weapons and the future of global conflict in the age of robots.

Elmo Motion Control's new EASIII software aims to streamline complex motion programming, boosting efficiency and safety in next-generation smart factories.

A new short film features a lifelike robotic dog, sparking conversations about AI's role in mental wellness and the complex future of companionship.

A new patent-pending platform embeds force plates directly into sports surfaces, promising to revolutionize athlete analytics, coaching, and fan engagement.

With $2M in new funding, Fermeate is using light to supercharge microbes, promising to slash costs and boost output in the precision fermentation industry.

A new game backed by science aims to improve youth well-being and inspire water stewardship. But can this 'conscious play' model build a real movement?

A new partnership brings sustainable, wash-free lab tech to the GCC & MENA, aiming to accelerate drug discovery in the world's fastest-growing life-science market.

With $6M in new funding and a $60M valuation, influencer-founded Neutonic is taking its nootropic drinks from podcast fame to global supermarket shelves.

AI Council 2026 reveals the industry's next chapter: European founders are flocking to SF, engineering is being reinvented, and video is set to break everything.

Backed by $37M and Hims & Hers co-founder Jack Abraham, Golden Child is challenging the fresh pet food market with a new science-backed food system.

A new AI video solution from V4b.AI promises to solve generative AI's accuracy problem, offering brands a scalable, shoot-free alternative for content.

Amid rising demand for flexible stays, Landing hires key leaders in finance and partnerships to accelerate its national expansion and solidify its market position.

A new cell-free therapy, Ultrasome™, shows a 93% response rate in a pilot study, offering a scalable, regenerative solution for millions with knee pain.